‘Moderna refused China request to reveal vaccine technology’
Moderna Inc (MRNA.O) has refused to hand over to China the core intellectual property behind the
Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids
Moderna Inc (MRNA.O) said on Friday it has requested U.S. authorisation for use of its
Moderna recalls thousands of COVID vaccine doses in Europe
Moderna Inc (MRNA.O) said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by
African Union to buy up to 110 million Moderna vaccines: officials
The African Union (AU) intends to buy up to 110 million doses of COVID-19 vaccine from Moderna Inc
Moderna plans African mRNA vaccine factory as pressure grows
Moderna plans to invest about $500 million to build a factory in Africa to make up to 500 million
Moderna is developing booster shot for new coronavirus variants, increases vaccine production target
Moderna Inc said on Wednesday it is working with US government scientists to study an experimental
Moderna says it believes vaccine will work against new variants
Moderna Inc said on Monday it believes its COVID-19 vaccine protects against new variants found in
Moderna to supply 100 to 125 million COVID-19 vaccine doses globally in first quarter
Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its
Pfizer, Moderna COVID-19 vaccines may be authorised for use within weeks – US official
COVID-19 vaccines from Pfizer Inc and Moderna Inc could be ready for US authorisation and
Moderna COVID-19 vaccine stability eases distribution challenges
Moderna Inc’s experimental COVID-19 vaccine is more stable than expected at temperatures that
Moderna could begin analyzing COVID-19 vaccine data within days, says Fauci
Moderna Inc could have data from a large trial of its experimental COVID-19 vaccine anywhere between
COVID-19 vaccine developers prepare joint safety pledge: WSJ
Several COVID-19 vaccine developers, including Pfizer Inc, Johnson & Johnson and Moderna Inc, plan
Moderna vaccine protects against COVID-19 in monkey study
Moderna Inc on Tuesday said its experimental COVID-19 vaccine induced a robust immune response and
Moderna’s COVID-19 vaccine shows promise in early study, shares soar
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage
Moderna, Switzerland’s Lonza strike deal on potential COVID-19 vaccine
Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the